Nitrous Oxide For Endoscopic Ablation of Refractory Barrett’s Esophagus (NO FEAR-BE)

Contact:

NCT Number:

Protocol:

AAAR9084

Study Status:

Active/Enrolling

Population:

Adult

Phase:

NA

dy is to evaluate the safety and effectiveness of using the C2 CryoBalloon Focal Ablation System to treat any remaining Barrett’s Esophagus after receiving Radiofrequency Ablation (RFA).

Are you Eligible? (Inclusion Criteria)

  • Are you at least 18 years of age?
  • Do you have a history of esophageal cancer?
  • Are you willing to undergo an experimental treatment for your type of cancer?

Specialty Area(s)

Barrett's Esophagus

Principal Investigator

Trial Location(s)

CUIMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032